Nicolas VABRET
Title
Cited by
Cited by
Year
Immunology of COVID-19: current state of the science
N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ...
Immunity 52 (6), 910-941, 2020
9852020
Sensing microbial RNA in the cytosol
N Vabret, JM Blander
Frontiers in immunology 4, 468, 2013
482013
Global cancer transcriptome quantifies repeat element polarization between immunotherapy responsive and T cell suppressive classes
A Solovyov, N Vabret, KS Arora, A Snyder, SA Funt, DF Bajorin, ...
Cell reports 23 (2), 512-521, 2018
422018
The biased nucleotide composition of HIV-1 triggers type I interferon response and correlates with subtype D increased pathogenicity
N Vabret, M Bailly-Bechet, V Najburg, M Müller-Trutwin, B Verrier, ...
PloS one 7 (4), e33502, 2012
372012
Advancing scientific knowledge in times of pandemics
N Vabret, R Samstein, N Fernandez, M Merad
Nature reviews Immunology 20 (6), 338-338, 2020
322020
Sinai Immunology Review Project
N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ...
Immunology of COVID-19: current state of the science. Immunity 52 (6), 910-941, 2020
322020
Sequence-specific sensing of nucleic acids
N Vabret, N Bhardwaj, BD Greenbaum
Trends in immunology 38 (1), 53-65, 2017
322017
Large-Scale Nucleotide Optimization of Simian Immunodeficiency Virus Reduces Its Capacity To Stimulate Type I Interferon In Vitro
N Vabret, M Bailly-Bechet, A Lepelley, V Najburg, O Schwartz, B Verrier, ...
Journal of virology 88 (8), 4161-4172, 2014
232014
Antibody responses to SARS-CoV-2 short-lived
N Vabret
Nature Reviews Immunology 20 (9), 519-519, 2020
222020
Identification of RNA partners of viral proteins in infected cells
AV Komarova, C Combredet, O Sismeiro, MA Dillies, B Jagla, ...
RNA biology 10 (6), 943-956, 2013
152013
SARS-CoV-2: the many pros of targeting PLpro
CB McClain, N Vabret
Signal Transduction and Targeted Therapy 5 (1), 1-2, 2020
142020
Innate immune system activation by viral RNA: How to predict it?
M Kondili, M Roux, N Vabret, M Bailly-Bechet
Virology 488, 169-178, 2016
82016
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010
S Brinckmann, K Da Costa, MJ van Gils, D Hallengärd, K Klein, L Madeira, ...
Journal of translational medicine 9 (1), 1-12, 2011
82011
Y-RNAs lead an endogenous program of RIG-I agonism mobilized upon RNA virus infection and targeted by HIV
N Vabret, V Najburg, A Solovyov, P Šulc, S Balan, G Beauclair, M Chazal, ...
bioRxiv, 773820, 2019
62019
Preclinical data from SARS-CoV-2 mRNA vaccine
N Vabret
Nature Reviews Immunology 20 (8), 461-461, 2020
52020
Hydroxychloroquine: small effects in mild disease
R Levantovsky, N Vabret
Nature Reviews Immunology 20 (6), 350-350, 2020
52020
Highlights from a year in a pandemic
M Merad, N Vabret
Journal of Experimental Medicine 218 (5), e20210220, 2021
32021
Measuring innate immune responses to bacterial viability
J Moretti, N Vabret, JM Blander
Innate Immune Activation, 167-190, 2018
32018
Enhanced gene silencing in cells cured of persistent virus infection by RNA interference
I Pelletier, A Saulnier, C Brisac, S Jegouic, N Vabret, F Tangy, B Blondel, ...
Journal of virology 84 (13), 6880-6885, 2010
32010
Abstracts from AIDS Vaccine 2010 Atlanta, Georgia, USA 28 September–1 October, 2010
JI Mullins, GN Pavlakis, BK Felber, C Brander, S Le Gall, D Weiner, ...
AIDS Research and Human Retroviruses 26 (10), A-1-A-184, 2010
12010
The system can't perform the operation now. Try again later.
Articles 1–20